Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diagnosis and management of porphyria.

Literature DB >> 10856069

Diagnosis and management of porphyria.

H Thadani¹, A Deacon, T Peters.

Abstract

Mesh：

Year: 2000 PMID： 10856069 PMCID： PMC1127427 DOI： 10.1136/bmj.320.7250.1647

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

31 in total

Review 1. Agents affecting porphyrin formation and secretion: implications for porphyria cutanea treatment.

Authors: V Kordac; M Jirsa; P Kotal; M Kaláb; J Cervinka; A Kotyk; P Martásek
Journal: Semin Hematol Date: 1989-01 Impact factor: 3.851

Review 2. Laboratory investigation of the porphyrias.

Authors: G H Elder; S G Smith; S J Smyth
Journal: Ann Clin Biochem Date: 1990-09 Impact factor: 2.057

3. Pregnancy and the acute porphyrias.

Authors: M J Brodie; M R Moore; G G Thompson; A Goldberg; R A Low
Journal: Br J Obstet Gynaecol Date: 1977-10

4. Acute intermittent porphyria with seizures. Anticonvulsant medication-induced metabolic changes.

Authors: R I Birchfield; M L Cowger
Journal: Am J Dis Child Date: 1966-12

5. Grand mal seizures and acute intermittent porphyria. The problem of differential diagnosis and treatment.

Authors: C R Magnussen; J M Doherty; R A Hess; D P Tschudy
Journal: Neurology Date: 1975-12 Impact factor: 9.910

6. A plasma porphyrin fluorescence marker for variegate porphyria.

Authors: M B Poh-Fitzpatrick
Journal: Arch Dermatol Date: 1980-05

Review 7. Free radicals involvement in neurological porphyrias and lead poisoning.

Authors: H P Monteiro; E J Bechara; D S Abdalla
Journal: Mol Cell Biochem Date: 1991-04-24 Impact factor: 3.396

8. Low-dose oral chloroquine in the treatment of porphyria cutanea tarda.

Authors: R E Ashton; J L Hawk; I A Magnus
Journal: Br J Dermatol Date: 1984-11 Impact factor: 9.302

9. Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.

Authors: H L Bonkowsky; P R Sinclair; S Emery; J F Sinclair
Journal: Neurology Date: 1980-06 Impact factor: 9.910

10. Porphyrias, porphyrins and hepatocellular cancer.

Authors: N O Bengtsson; L Hardell
Journal: Br J Cancer Date: 1986-07 Impact factor: 7.640

19 in total

1. Anaesthesia is also risky in patients with porphyria.

Authors: S D Baker; B Taylor
Journal: BMJ Date: 2000-10-21

2. Regional Variation in Analytical Techniques used in the Diagnosis and Monitoring of Porphyria: a Case for Harmonisation?

Authors: Christiaan W Sies; Virginia Cronin; Christopher M Florkowski; Jan Gill; Janine Grant; Victor Poulos; John Zoanetti
Journal: Clin Biochem Rev Date: 2015-05

10. Mass-spectrometric profiling of porphyrins in complex biological samples with fundamental, toxicological, and pharmacological applications.

Authors: Sarah A Sullivan; Bennett R Streit; Ethan L Ferguson; Paul A Jean; Debra A McNett; Louis T Llames; Jennifer L DuBois
Journal: Anal Biochem Date: 2015-03-10 Impact factor: 3.365

Diagnosis and management of porphyria.

Review 1. Agents affecting porphyrin formation and secretion: implications for porphyria cutanea treatment.

Review 2. Laboratory investigation of the porphyrias.

3. Pregnancy and the acute porphyrias.

4. Acute intermittent porphyria with seizures. Anticonvulsant medication-induced metabolic changes.

5. Grand mal seizures and acute intermittent porphyria. The problem of differential diagnosis and treatment.

6. A plasma porphyrin fluorescence marker for variegate porphyria.

Review 7. Free radicals involvement in neurological porphyrias and lead poisoning.

8. Low-dose oral chloroquine in the treatment of porphyria cutanea tarda.

9. Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.

10. Porphyrias, porphyrins and hepatocellular cancer.

1. Anaesthesia is also risky in patients with porphyria.

2. Regional Variation in Analytical Techniques used in the Diagnosis and Monitoring of Porphyria: a Case for Harmonisation?

3. CYP2D6 polymorphisms in patients with porphyrias.

4. Anxiety and depression in the acute porphyrias.

5. Suxamethonium in the intensive care unit: "Fool me once, shame on you; fool me twice, shame on me".

6. The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine.

7. Neuropsychiatric porphyria in patients with refractory epilepsy: report of three cases.

8. Self-rated psychosocial consequences and quality of life in the acute porphyrias.

9. A retrospective analysis of outcome of pregnancy in patients with acute porphyria.

10. Mass-spectrometric profiling of porphyrins in complex biological samples with fundamental, toxicological, and pharmacological applications.